FDA Approvals

Date Posted
Article Title
1/30/2012
1/27/2012
Bydureon Approved for Type 2 Diabetes

A once-weekly injection

1/27/2012
Drug Approved for Advanced Kidney Cancer

Inlyta is for people who don't respond to another drug

1/20/2012
1/18/2012
Voraxaze Approved to Treat High Levels of Chemo Drug

Blood amounts can rise due to kidney failure

1/16/2012
1/3/2012
Pneumonia Vaccine Approved for Older People

Prevnar 13 shot sanctioned for people 50 and up

12/21/2011
12/20/2011
Edarbyclor Approved for High Blood Pressure

Condition affects about 1 in 3 Americans

12/16/2011
New Device Approved for Children With Heart Failure

To be used until donor heart can be found

12/1/2011
First Generic Lipitor Approved

Widely used statin drug helps lower bad cholesterol

11/18/2011
11/16/2011
Jakafi Approved for Rare Bone-Marrow Disease

First drug in U.S. sanctioned for myelofibrosis

11/11/2011
FDA Approves First Umbilical Cord Blood Product

Hemacord stem cell product sanctioned for certain blood cancers and related disorders

11/7/2011
Erbitux Approval Expanded to Include Head and Neck Cancer

Most common in men, people older than 50

11/4/2011
Xarelto Approved to Prevent Stroke in People With Abnormal Heartbeat

Atrial fibrillation affects more than 2 million Americans

11/3/2011
11/2/2011
Device Approved to Remedy Abdominal Aneurysms

In people with smaller arteries

11/2/2011
MelaFind Device Approved to Detect Melanoma

A deadly form of skin cancer

10/31/2011
Exparel Approved for Post-Surgery Pain

Provides relief up to 72 hours